Cite
MLA Citation
Yen-Ting Lin et al.. “Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer.” Lung cancer, vol. 145, 2020, pp. 1–9. http://access.bl.uk/ark:/81055/vdc_100104107386.0x00004d